JPM 2026: Key Insights and Connections

To assess how the JPM Healthcare Conference translated into real communications impact, Fullintel analyzed earned media coverage published between January 10 and January 17 with a focus on influence—not just volume. This approach reflects two fundamental shifts in how audiences now consume information: the growing role of AI-generated search outputs such as ChatGPT and AI Overviews—where zero-click behavior now dominates—and the continued reliance on social platforms, where roughly seven in ten people get their news. 
 
As a result, the analysis examines not only traditional indicators like reach, engagement, sentiment, and topical volume, but also the percentage of JPM-related coverage appearing in outlets most likely to surface in AI systems, as well as the share of content that achieved social amplification. 
 
Together, these measures provide a more predictive, science-based view of which narratives were positioned to earn trust and reach audiences through the channels they increasingly rely on for information.

Angela Dwyer
VP of Insights, Fullintel
2025 AMEC Executive Professional of the Year
IPR Measurement Commission

Fullintel

How Media Coverage Unfolded at JPM 2026

This sample report shows the type of analysis we provide pharmaceutical and healthcare organizations following major industry conferences.

What you’ll see in this sample:
  • Which companies dominated media conversations and why
  • Sentiment shifts throughout the conference timeline
  • Executive visibility and message penetration
  • Outlet and journalist coverage patterns
  • Early signals of reputational risk or opportunity

Scroll through the report here —> to see how comprehensive event analysis helps teams understand their conference ROI and inform next steps.

PMorgan Healthcare
Fullintel

Turn Conference Coverage Into Strategic Advantage

JPM, BIO, ASCO—these conferences represent significant investments. Our event-focused media analysis helps you understand what happened, why it matters, and what to do next.

Pharma and healthcare teams use this analysis to:
  • Justify conference participation with quantified media impact
  • Identify which messages broke through and which fell flat
  • Spot competitive moves and emerging narratives early
  • Brief executives with complete coverage context, not just clips
  • Shape post-event follow-up and next conference strategy

We’ve analyzed media coverage for 200+ healthcare conferences. The teams that use this analysis make better decisions about where to invest, what to say, and how to measure success.

Circle
Circle

While this sample focuses on JPM 2026, the same analysis applies to upcoming healthcare and life sciences conferences throughout the year. Teams use this approach both to review recent coverage and to prepare for what’s ahead—understanding which narratives gain traction, where influence builds, and how to adjust messaging before the next event.

Talk to Me About Your Conference Coverage

Whether you’re reviewing coverage from a recent conference or preparing for what’s next, we help pharma and healthcare teams understand media visibility, message penetration, and competitive positioning across major industry events.

Icon

    Try Fullintel Today

    Don’t just monitor the news;
    deliver smarter media intelligence with Fullintel.

    Explore how our media intelligence platform, backed by human-trained AI and supported by expert media analysts, can save you time and money. 

    Book a Demo
    Custom Pricing
    Circle
    Circle